A 75-year-old woman was admitted to our hospital because of general fatigue. She had suffered from sarcoidosis during her 40s with remission, but subsequently she experienced progression of hypercalcemia and renal dysfunction for 7 years. On admission, she showed marked hypercalcemia (up to 15.5 mg/dl) and renal failure (serum creatinine 2.5 mg/dl). Plasma intact PTH level was elevated (up to 190 pg/ml), and thyroid ultrasonography and 99m Tc-MIBI scintigraphy detected a parathyroid mass, which was surgically removed and histologically confirmed to be a parathyroid adenoma. However, even after surgery her serum calcium remained elevated, but subsequent administration of glucocorticoid for sarcoidosis completely normalized her hypercalcemia. The simultaneous occurrence of primary hyperparathyroidism and sarcoidosis is rare, and our data suggest that high plasma PTH and 1,25(OH)D exerted an additive effect on the occurrence of severe hypercalcemia. HYPERCALCEMIA is known to be caused by a variety of hormonal dysfunctions. Elevated plasma parathyroid hormone (PTH) is well known to induce hypercalcemia by enhancing renal reabsorption of calcium (Ca) and activation of osteoclasts [1] . PTH-related protein (PTH-rP) secreted from tumor cells also causes hypercalcemia by a similar mechanism [2] . In addition, high plasma 1,25(OH) 2 D3, which can be due to ectopic activation of 1α-hydroxylase (1α-OHase) [3] or to administration of a high dose of 1α(OH)D3, elicits hypercalcemia by enhancing the absorption of dietary Ca in the small intestine. Regardless of the causes, sustained hypercalcemia results in polyuria, renal dysfunction, muscle weakness, pancreatitis, gastric/ duodenal ulcer, and psychiatric symptoms.
HYPERCALCEMIA is known to be caused by a variety of hormonal dysfunctions. Elevated plasma parathyroid hormone (PTH) is well known to induce hypercalcemia by enhancing renal reabsorption of calcium (Ca) and activation of osteoclasts [1] . PTH-related protein (PTH-rP) secreted from tumor cells also causes hypercalcemia by a similar mechanism [2] . In addition, high plasma 1,25(OH) 2 D3, which can be due to ectopic activation of 1α-hydroxylase (1α-OHase) [3] or to administration of a high dose of 1α(OH)D3, elicits hypercalcemia by enhancing the absorption of dietary Ca in the small intestine. Regardless of the causes, sustained hypercalcemia results in polyuria, renal dysfunction, muscle weakness, pancreatitis, gastric/ duodenal ulcer, and psychiatric symptoms.
We recently experienced an interesting case of severe hypercalcemia due to both primary hyperparathyroidism and sarcoidosis. Surgical removal of the parathyroid adenoma only partially improved her serum Ca levels, and subsequent administration of glucocorticoid for sarcoidosis completely normalized the hypercalcemia. Considering the differential pathophysiology of hypercalcemia in hyperparathyroidism and sarcoidosis, our case suggests that elevation in plasma PTH and Vitamin D3 by primary hyperparathyroidism and sarcoidosis, respectively, has an additive effect on the regulation of plasma Ca level.
Case report
A 75-year-old woman was admitted to our hospital because of general fatigue and anorexia. In her 40s, she had suffered from histologically-proven pulmonary sarcoidosis with subsequent remission. In her late 60s, she was pointed out to have hypercalcemia and renal dysfunction at a local medical clinic [serum Ca and cre-atinine (Cr) levels were around 13 mg/dl, and 2-3 mg/ dl, respectively], but the causative disease(s) was not determined. On admission, she was alert and oriented, but was mildly dehydrated. Her blood pressure was 160/90 mmHg. Her chest X-ray examination was unremarkable, and no sign of subperiosteal absorption was observed in her hands or skull. Blood examination revealed that she had chronic renal failure [serum Cr 2.5 mg/dl, blood urea nitrogen (BUN) 32 mg/dl, creatinine clearance (Cc r ) 12.2 ml/min] with moderate proteinuria (1 g/day). Abdominal CT scan showed arterial calcification and renal atrophy (especially in the left kidney) without intrarenal calcification. She also had marked hypercalcemia [corrected serum Ca (cCa) by Payne's equation 13.9 mg/dl]. Her plasma intact PTH (iPTH) and 1,25(OH) 2 D3 were 100-190 pg/ml and 46 pg/ml, respectively. Serum angiotensin converting enzyme (ACE) and lysozyme levels were both elevated [37.8 IU/l (reference range 8.3-21.4) and 63.4 mg/ml (reference range 5-10), respectively]. Plasma PTH-rP was undetectable.
Imaging analysis by ultrasonography revealed a hypoechoic mass (0.8 × 0.6 × 0.6 cm), suggesting the presence of an adenoma of her left lower parathyroid gland (Fig. 1A) as well as two hypo-isoechoic thyroid mass lesions in the right lobe (2.1 × 1.5 × 1.4 and 2.5 × 2.0 × 1.7 cm, not shown). Enhanced uptake of 99m Tc-MIBI in the left lobe of the thyroid gland, as well as in the right lobe, which was probably influenced by the presence of the thyroid adenomas, was observed (Fig. 1B) , supporting the clinical diagnosis of primary hyperparathyroidism. Bone mineral density of her lumbar spine, estimated by dual X-ray absorptometry (DXA), was low [65% of the young adult mean (YAM)]. For her marked hypercalcemia, bisphosphonate and/or eel calcitonin (elcitonin) was initially used, but only limited and temporary effects were obtained (Fig. 2) . Considering her age and renal function, therefore, parathyroidectomy was carried out under local anesthesia, and the removed tumor was histologically confirmed to be a parathyroid adenoma (Fig. 3) . Unexpectedly, however, her serum Ca level was only partially improved (Fig. 2) , and hypercalcemia of around 11-12 mg/dl continued despite the marked decrease in plasma iPTH (9 pg/ml). Furthermore, her serum ACE (30.6 IU/l) and serum 1,25(OH) 2 D3 (111 pg/ ml) remained high, and gallium scintigraphy showed increased uptake of the hilar region (so-called λ-sign) (Fig. 1C) , suggesting the presence of bilateral hilar lymphadenopathy (BHL). The chest CT scan also revealed the swelling of the bilateral hilar lymph nodes (Fig. 1D) . Although no other signs and symptoms of sarcoidosis were observed, we considered the sustained activity of the disease and began the oral administration of prednisolone (20 mg/day). Subsequently, her serum Ca and ACE were completely normalized, and 1,25(OH) 2 D3 levels were decreased to undetectable levels. Her renal function improved but the state of chronic renal failure persisted. Interestingly, during the follow-up period, we recognized that her serum Ca became rather low with an increase in plasma iPTH, suggesting the occurrence of hungry bone syndrome, and oral administration of 1α(OH)D3 (1 µg/day) was started to prevent the hypercalcemia.
Discussion
In primary hyperparathyroidism, excessive secretion of PTH causes hypercalcemia by increasing the renal reabsorption of Ca and the reabsorption of Ca from bone [1] . It also increase Ca absorption in the gut by increasing the synthesis of 1,25(OH) 2 D3 via enhanced 1α-OHase expression in the kidney. In contrast, in sarcoidosis, hypercalcemia is known to be caused solely by high 1,25(OH) 2 D3 via overexpression of 1α-OHase in the macrophage of the granulomatous tissues. However, the pathophysiology of Ca metabolism when both disorders coexist is not known because very few cases with simultaneous occurrence of the diseases have been reported [4] [5] [6] [7] . Recently Kinoshita et al. [7] extensively characterized a combined case of both disorders, but removal of parathyroid adenoma completely normalized the hypercalcemia of the patient, and thus the relative role of PTH and 1,25(OH) 2 D3 in the occurrence of hypercalcemia was still not clear. In this report, we showed that both parathyroid adenoma and sarcoidosis played a significant causative role in the patient's severe hypercalcemia in an additive manner.
In the current case, the renal function of the patient was substantially decreased, and indeed plasma 1,25(OH) 2 D3 decreased to an undetectable level after the remission of sarcoidosis, probably because of the abolished 1αOHase activity in the diseased kidney. Thus, intestinal and skeletal, but not renal, factors were responsible for the hypercalcemia before the parathyroidectomy. In contrast, the hypercalcemia which continued after the parathyroidectomy is primarily at- Fig. 2 . Clinical course of the patient. iPTH, intact PTH (pg/ml); VD 3 , 1,25(OH) 2 D3 (pg/ml); ACE, angiotensin converting enzyme (IU/l); cCa, corrected serum Ca (mg/dl). The shaded area designates the reference range.
tributable to the high 1,25(OH) 2 D3 caused by ectopic activation of vitamin D3 in sarcoidosis, because at that stage plasma PTH was markedly suppressed by the concomitant hypercalcemia. Thus, we assume that the severe hypercalcemia (cCa>15 mg/dl) in this patient on admission was caused by independent mechanisms of the two diseases, and that the removal of hyperparathyroidism only partially restored her hypercalcemia, whereas subsequent restoration of her sarcoidosis completely normalized the plasma Ca level. It is of interest that elevated 1,25(OH) 2 D3 derived from sarcoidosis is reported to exert a suppressive effect on PTH secretion from the parathyroid adenoma, by showing an inverse relationship between plasma 1,25(OH) 2 D3 and PTH [7] . Unfortunately, however, in our case, parathyroidectomy was carried out before the administration of glucocorticoid with the resultant decrease in 1,25(OH) 2 D3, and therefore we could not analyze the issue in this case. Substantial increase in plasma iPTH (130-200 pg/ml) was recognized when the activity of sarcoidosis subsided and the plasma 1,25(OH) 2 D3 became undetectable, and this increase may be caused primarily by hypocalcemia due to the hungry bone syndrome as well as chronic renal failure.
The cause of her renal failure is not completely clear. CT scan of the kidney showed renal atrophy and advanced atherosclerosis of the abdominal arteries, suggesting nephrosclerosis as a primary cause of her renal dysfunction. In addition, chronic hypercalcemia is also known to impair renal function, although no obvious calcification in the kidney was recognized. Only tran- sient improvement in the serum Cr level was observed following the treatment of hyperparathyroidism and sarcoidosis, probably because of the irreversible organic damage that had occurred to her renal tissue.
